Matricelf (MTLF) Stock Overview
A biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
MTLF Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
100% Patient Improvement in trial puts this $16M Biotech on the radar
Key Takeaways Hoth is a clinical-stage biotech with a diversified pipeline across oncology, neurology, and inflammation. Lead drug HT-001 targets cancer treatment related rashes, a multi-hundred-million-dollar niche where no approved therapies exist.
Matricelf Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₪4.40 |
| 52 Week High | ₪7.78 |
| 52 Week Low | ₪2.04 |
| Beta | 0.46 |
| 1 Month Change | -37.03% |
| 3 Month Change | 90.31% |
| 1 Year Change | 27.02% |
| 3 Year Change | -27.02% |
| 5 Year Change | n/a |
| Change since IPO | -16.73% |
Recent News & Updates
Recent updates
Shareholder Returns
| MTLF | IL Biotechs | IL Market | |
|---|---|---|---|
| 7D | -5.9% | 3.1% | 7.0% |
| 1Y | 27.0% | -8.6% | 58.9% |
Return vs Industry: MTLF exceeded the IL Biotechs industry which returned -8.6% over the past year.
Return vs Market: MTLF underperformed the IL Market which returned 58.9% over the past year.
Price Volatility
| MTLF volatility | |
|---|---|
| MTLF Average Weekly Movement | 20.6% |
| Biotechs Industry Average Movement | 6.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in IL Market | 7.8% |
| 10% least volatile stocks in IL Market | 3.5% |
Stable Share Price: MTLF's share price has been volatile over the past 3 months compared to the IL market.
Volatility Over Time: MTLF's weekly volatility has increased from 11% to 21% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 12 | Gil Hakim | matricelf.com |
Matricelf Ltd, a biotechnology company, develops a platform for autologous tissue engineering for various medical conditions. The company’s regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson’s disease, and myocardial infarction, as well as for 3D bioprinting. Matricelf Ltd was incorporated in 2019 and is based in Ness Ziona, Israel.
Matricelf Ltd Fundamentals Summary
| MTLF fundamental statistics | |
|---|---|
| Market cap | ₪73.71m |
| Earnings (TTM) | -₪18.62m |
| Revenue (TTM) | n/a |
Is MTLF overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MTLF income statement (TTM) | |
|---|---|
| Revenue | ₪0 |
| Cost of Revenue | ₪272.00k |
| Gross Profit | -₪272.00k |
| Other Expenses | ₪18.35m |
| Earnings | -₪18.62m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.11 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did MTLF perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/03 02:56 |
| End of Day Share Price | 2025/09/30 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Matricelf Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.